The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer

计划入组 150 人 · 首次发布于 2020 年 12 月 17 日

Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection

计划入组 15 人 · 首次发布于 2019 年 10 月 31 日

Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC

计划入组 149 人 · 首次发布于 2009 年 4 月 13 日

Thiocolchicoside

C₂₇H₃₃NO₁₀S

TCC1727

DP-3005

GWT-TUD GmbH

Germany

TKC

TAC

Canada

Grove Biopharma Secures $30M Funding, Expands to New R&D Facility in Chicago's Fulton Market

Digital Health Funding Roundup: Aignostics Secures $34M Series B for AI-Powered Pathology Platform

Akston Biosciences and Purdue University Launch Immunotherapy Trial for Canine Bladder Cancer